HEMOMINAS (Blood Bank Foundation)

HEMOMINAS was set up as a foundation of Minas Gerais Health Department in 1985. It aimed at arranging and opening up a hematological and hemotherapic system in State of Minas Gerais

HEMOMINAS currently grants almost 90% of transfusions in Minas Gerais, but its goal is to attain 100% transfusions for Single Health System in Minas Gerais.

HEMOMINAS outpatient units provide multi-disciplinary treatment for coagulopahties and hemoglobinopathies. Owing to its 13 outpatient units providing multi-disciplinary assistance to patients with sickle cell anemia,

HEMOMINAS is currently a reference in treatment of blood-related diseases. It, for instance, initiates treatment for patients with sickle cell disease as soon as the disease is diagnosed by Neonatal Screening.

HEMOMINAS, in partnership with CEHMOB, Federal University of Minas Gerais and Minas Gerais Health Department, has also promoted “Trainings on Urgency Care for Sickle Cell” aiming at improving assistance provided to patients with sickle cell disease.

HEMOMINAS records currently contain around 4 thousand patients with sickle cell anemia and around 1,500 patients with coagulopathies. These records account for 23 units throughout State of Minas Gerais. Two other units and a Center of Biologic Tissues (CETEBIO) must be fully operating in the next few years. CETEBIO project focuses on demands of tissue transplantation by patients from Brazilian Single Health System. Lack of tissues is a common ongoing reality for these patients and accounts for tissue importation in extreme cases.

HEMOMINAS, alongside NUPAD (Support Diagnosis Center), also founded CEHMOB (Center for Education and Aid on Hemoglobinopathies). It is a groundbreaking center committed to providing support to state outpatient clinics and ambulatory units. CEHMOB basically aims at supplying emergency care to patients with sickle cell disease as well as implementing a simplified protocol standardized to all public urgency care units of State of Minas Gerais. Both goals are intended to reduce morbidity and mortality among patients with sickle cell disease.

Mission

To carry out high-standard and social responsibility-based hematologic and hemotherapic services.

Vision

To be nationally and internationally acknowledged as a high-standard public organization on hemathology and hemotherapy.

Values

We are committed to lifelong improvement;
Our actions are ethic-oriented;
We perform services with social responsibility;
We respect and valorize the human being.

For more information about HEMOMINAS, access www.hemominas.mg.gov.br